NPC Archive Item: Time running out for co-proxamol users

NOTE – This is an archive post from the NPC and has not been updated since first publication. Therefore, some hyperlinks may no longer be working. Licences for co-proxamol will be cancelled at the end of 2007 – less than two months away. The MHRA has reminded health professionals of this in the latest issue […]

NPC Archive Item: 4th Drug Safety Update from MHRA/CHM

NOTE – This is an archive post from the NPC and has not been updated since first publication. Therefore, some hyperlinks may no longer be working. The Drug Safety Update is an NHS Evidence accredited provider The MHRA and CHM have published the latest issue of Drug Safety Update (4th November 2007). This contains information […]

NPC Archive Item: Lumiracoxib▼ withdrawn from Canadian Market

NOTE – This is an archive post from the NPC and has not been updated since first publication. Therefore, some hyperlinks may no longer be working. Health Canada (Santé Canada) has announced (4th October) that it has stopped the sale of the anti-inflammatory drug lumiracoxib▼ (Prexige®) in Canada and will cancel the drug’s market authorisation […]

NPC Archive Item: MHRA warns about NSAIDs in Drug Safety Update

NOTE – This is an archive post from the NPC and has not been updated since first publication. Therefore, some hyperlinks may no longer be working. The Drug Safety Update is an NHS Evidence accredited provider The third edition of Drug Safety Update from the Medicines and Healthcare products Regulatory Agency (MHRA) has highlighted updated […]

NPC Archive Item: Lumiracoxib ‘not approved’ by FDA

NOTE – This is an archive post from the NPC and has not been updated since first publication. Therefore, some hyperlinks may no longer be working.   What is the story here? The Food and Drugs Administration (FDA) has issued a ‘not approvable‘ letter for lumiracoxib (Prexige®) according to a press release from the manufacturer. […]